Abiopharma

DAYBU® (trofinetida) recibe una recomendación positiva por parte del CHMP para su aprobación en la Unión Europea

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bio-Techne Corporation (NASDAQ: TECH)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Synaptics Incorporated (NASDAQ: SYNA)

Curaleaf to Report Second Quarter 2026 Financial and Operational Results

Malattie rare – Dal CHMP parere positivo per trofinetide per il trattamento della sindrome di Rett

Calix, Inc. (CALX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Microsoft Corporation (MSFT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

DAYBU® (Trofinetide) vom CHMP für die Zulassung in der Europäischen Union empfohlen

Nano-X Imaging Ltd. (NNOX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit